ChemTrak to submit 510(k) for H. pylori physician test by year-end.
This article was originally published in The Gray Sheet
Executive SummaryCHEMTRAK 510(K) FOR H. PYLORI PHYSICIAN-OFFICE TEST will be sent to FDA by year-end, according to the company. ChemTrak says the 510(k) for the physician-use test will be submitted upon completion of multicenter clinical trials involving "a few hundred patients." The "one-step" whole blood test can indicate the presence or absence of H. pylori antibodies "in minutes," ChemTrak says. The company plans to submit a 510(k) for a home-use version of the technology in 1996.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.